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Differences of Sex Development (DSD; also known by other labels, including Intersex) is an 
umbrella term describing a heterogeneous group of congenital conditions that impact the course 
of sex determination and differentiation (Cools et al., 2018; Lee, Houk, Ahmed, & Hughes, 2006; 
see Table 1 for examples). DSD are estimated to affect 1/4,500 births (Lee, et al., 2006) and 
can have a range of complex medical, psychological and social impacts (Sandberg, Gardner, & 
Cohen-Kettenis, 2012; Wisniewski et al., 2019; Wisniewski & Sandberg, 2015). For example, 
DSD may be associated with: atypical and/or ambiguous genitalia; sex discordant features (e.g., 
sex chromosomes that do not match the gender in which the person is reared; gynecomastia; 
excess facial and body hair in females); complex proxy decision making regarding gender of 
rearing and whether or when to pursue genital and/or gonadal surgery; infertility or impaired 
fertility; and sexual dysfunction.  
Table 1. Example of a DSD Classification System.  
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Note. Table from Chan, Y.-M., Hannema, S. E., Achermann, J. C., & Hughes, I. A. (2020). 
Disorders of Sex Development. In S. Melmed, R. J. Auchus, A. Goldfine, B., R. J. Koenig, & C. 
J. Rosen (Eds.), Williams Textbook of Endocrinology (Fourteenth ed., pp. 867-936.e814). 
Elsevier 
Historically, as in many areas of medicine, DSD management, was paternalistic (Karkazis, 
Tamar-Mattis, & Kon, 2010; Siminoff & Sandberg, 2015). In accordance with the optimal gender 
policy (Money, Hampson, & Hampson, 1955a, 1955b), medical treatment centered on 
normalizing the child’s genitalia through gender-validating surgery performed during infancy in 
order to protect the child and family from stigma and psychological distress (Nordenström & 
Thyen, 2014; Roen & Pasterski, 2014). Although secrecy was not an explicit tenet of the optimal 
gender policy (Money, 1968, 1994), it was common for physicians (and caregivers) to withhold 
information about DSD diagnoses and related medical treatment from affected individuals  
Unfortunately, this secretive approach engendered shame, stigma, and distrust in healthcare 
providers and had other negative physical and psychosocial impacts for individuals treated 
during this era (Chase, 1998; Frader et al., 2004).  
Advances in genetics, diagnostics, and treatment approaches, combined with continued reports 
of dissatisfaction with care practices from advocacy groups, patients and families, led to a 
consensus meeting of patients and healthcare professionals and subsequent creation of the 
2006 Consensus Statement (Hughes, Nihoul-Fékété, Thomas, & Cohen-Kettenis, 2007; Lee et 
al., 2006). Care practices have changed significantly in accordance with the 2006 Consensus 
statement, including recommendations for early, ongoing information sharing with affected 
individuals (Lee et al., 2006; Roen & Pasterski, 2014) to reduce the likelihood of shame and 
stigma potentially associated with the DSD diagnosis and related detrimental effects on the 
individual’s psychosocial adjustment and well-being.    
DSD and related treatments can impact psychosocial functioning for both affected individuals 
and their caregivers (de Vries et al., 2019; Kleinemeier, Jürgensen, Lux, Widenka, & Thyen, 
2010). Stigma is often cited as a contributing factor to poor psychosocial outcomes in persons 
with DSD and their caregivers. For example, Rolston et al. (2015) found that stigma is 
associated with increased risk for emotional distress and social isolation among individuals with 
DSD (Rolston et al., 2015). According to Goffman (1963), stigma is “an attribute that is deeply 
discrediting” and that diminishes a person in the eyes of others “from a whole and usual person 
to a tainted, discounted one” (p. 3). More recently, stigma has been further categorized into two 
types, “enacted” and “felt stigma”. Enacted stigma refers to instances of negative or unfair 
treatment such as discrimination (e.g., not hiring a person with a physical difference) and/or 
other types of unwanted attention/treatment because of the devalued characteristic (e.g., 
avoiding or staring at a person with physical differences, teasing/bullying; Scambler, 2009). Felt 
stigma refers to the affected individual’s fear of enacted stigma or anticipation of social rejection. 
In other words, felt stigma reflects the belief that negative treatment will occur if the difference is 
exposed (Quinn & Earnshaw, 2013).  
At the time of their child’s birth and during childhood, parents/caregivers of children with DSD 
may fear or experience stigma related to the child’s DSD condition. Stigma in turn can be 
detrimental to parents’ coping and use of social support, particularly if they are fearful to 
disclose the child’s condition to others. Parental concerns about experienced or anticipated 
stigma may persist throughout childhood and adolescence as parents may worry that their 
child’s participation in daily (e.g., using a public restroom) or specific activities (e.g., 
extracurricular activities like swimming) will inadvertently reveal the child’s DSD-related 
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differences. Parents may also worry about whether their child will experience teasing and/or 
bullying if their differences are revealed. Furthermore, parents’ perceived/experienced stigma 
can impact how they communicate to their child about the DSD, inadvertently instilling shame 
and secrecy. 
As they grow older, individuals with DSD-related physical differences may experience feelings 
of self-consciousness and/or shame, particularly in situations where their difference could be 
exposed. They may also experience and/or fear teasing, bullying, or rejection because of their 
differences. These concerns may intensify during adolescence and adulthood when interest in 
forming romantic partnerships and when having children may take on greater salience and 
focus. Although, there is little longitudinal, prospective data about adjustment in persons with 
DSD over time and across developmental stages.  
While stigma is often cited as a factor that negatively affects well-being and adjustment, it is 
unknown how many studies have assessed stigma (enacted or felt) among parents/caregivers 
or individuals with DSD, nor how these studies were conducted. The goal of this scoping review 
is to examine evidence for stigma experiences/perceptions (felt or enacted) in 
parents/caregivers of children with DSD as well as youth/adults with DSD. A preliminary search 
for scoping and systematic reviews on stigma across DSD was conducted in 2020 and again in 
2021 with no scoping or systematic reviews identified. The objective of this scoping review is to 
investigate stigma experiences as reported by individuals with DSD (children, adolescents, 
adults) their parents/caregivers, and non-affected individuals (e.g., healthcare providers).  
Inclusion Criteria:  
 
 Qualitative or quantitative studies that evaluated stigma in DSD populations or stigma-
related attitudes towards individuals with DSD 
 Studies published in peer-reviewed journals 
 Studies published in the English language 
 Studies published after publication of the optimal gender policy (Money et al., 1955a, 
1955b) in 1955 
 Exclusion criteria: any article not written in English; articles written before 1955 
Types of participants 
 Parents, legal guardians or family members of children [of any age] with DSD defined in 
accordance with the 2006 Consensus Statement (Lee et al., 2006) as congenital 
conditions in which development of chromosomal, gonadal, or anatomic sex is atypical 
 Children, adolescents, adults with DSD (as defined above)  
 Non-affected adults or children (any age), as long as they are reporting on the stigma 
related to DSD (e.g., healthcare providers, policy-makers). 
Concept 
The concept of interest for this scoping review is understanding stigma in DSD.  
Context 
No particular context will be applied to this project. However, sources will be limited to those 
written in English. As such, this scoping review will include studies published from any cultural 
or regional setting that is written in the English language. 
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Types of evidence sources 
We will include the following study designs: 
 
Quantitative and qualitative primary research studies will be included in the scoping review. This 
will include randomized controlled trials, time series analyses, non-randomized studies, and 
observational studies, including controlled before-after studies, and pre-post studies.  
 
The following will be excluded: literature reviews, commentaries, book chapters, unpublished 
dissertations, and editorials. 
 
Methods: 
The methods used in this scoping review will follow the frameworks proposed by Arksey and 
O’Malley (2005) and Levac and colleagues (Peters et al., 2020), using the methods outlined in 
the JBI Manual for Evidence Synthesis. The review team followed a multi-step, iterative process 
for developing and refining the search strategy. 
 
Search Strategy:  
Description of strategy:  
The review team met with two informationists (LJ, KS) in early 2020. Using a short list of 
sentinel articles provided by the review team, the informationists were able to craft an initial 
search strategy that was used to inform the selection of potential databases, concepts, and 
search terms. The search strategies were developed to identify published primary studies. 
The databases that were selected for this project include Cochrane Library, PubMed, Ovid 
MEDLINE (Ovid MEDLINE(R) and Epub Ahead of Print, In-process & Other Non-INdexed 
Citations, Daily and Versions(R)), (ELSEVIER) Embase, (EBSCO) CINAHL Complete, 
(EBSCO) PsycInfo, (EBSCO) LGBT Life, and (ELSEVIER) Scopus. 
 
As a group, the team reviewed preliminary searches for scoping and systematic reviews on 
stigma across DSD in Cochrane Library and PubMed. This initial search was also used to 
identify relevant concepts, controlled vocabulary, and keywords.  
 
After initial search strategies were analyzed and refined, it was later determined that Ovid 
MEDLINE would be the preferred database for searching MEDLINE. As the searches were 
translated across the remaining databases, the entire team reviewed search terms and 
results for each database and provided feedback on controlled vocabulary and keywords. 
The final search strategy was built around three main concepts: disorders of sex 
development and stigma. The review team was also unable to provide translation for 
articles in languages other than English, so an English language limit was also applied to 
the searches. When available, publication limits were applied to exclude reviews, 
commentaries, and book chapters. The final searches were run on 12/8/2020, and EndNote 
X9 was used to manage citations, and to identify and remove duplicates. 
 
A complete search strategy for Ovid MEDLINE has been included in Appendix A.  
 
Supplemental strategies:  
A hand-search for non-indexed and difficult to locate studies will be conducted, including 
examining key journals. We will also scan the reference lists of all included articles. 
 
Source of evidence selection:  
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The review of sources will utilize the program DistillerSR. Article selection will be based on the 
inclusion/exclusion criteria described above and will include a review of title and abstract, 
followed by a full-article review.  
 
All reviewers will undergo a training process including reading relevant articles and reviewing 
the codebook developed for this project. Pilot testing will take place, including the entire review 
team completing a title/abstract and full-text review of 25 randomly selected articles, with the 
use of the inclusion/exclusion criteria and the codebook. Throughout pilot testing, the review 
team will meet to review and update inclusion/exclusion criteria and codebook. Screening will 
commence once all 25 articles have been reviewed and discussed and when there is at least 
75% agreement among reviewers. When completing the screening, at least 2 reviewers will 
review each source at each level (title abstract and full-article review) and disagreements will be 
reconciled by consensus or by a third reviewer. See Figure 1 for flowchart of review process. 
In accordance with the PRISMA-ScR statement (Tricco et al., 2018), a flowchart and narrative 
description of the evidence selection process will be created [from the search, source selection, 
duplicates, full-text retrieval, and any additions from third search, data extraction and 
presentation of the evidence].  
Figure 1. Review process 
 
Details will be provided in a table for all articles identified for inclusion in the final synthesis for 
this scoping review. Reasons for exclusion will also be provided about excluded articles. 
 
Data extraction/charting:  
 
The data extraction form will extract the following key information from each article:  
1. Author(s) 
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2. Year of publication 
3. Origin/country of origin (where the source was published or conducted) 
4. Aims/purpose 
5. Population and sample size within the source of evidence including sampling strategy 
(procedure followed to select sample) 
a. DSD diagnosis/identity, race, ethnicity, sex, gender, sexual orientation 
6. Methodology / methods (see Table 2 below) 
7. Stigma outcomes and details of these (e.g. how measured) 
 
The data extraction form will be utilized during the pilot phase of the project and further refined, 
as needed. If additional data is determined to be needed during the screening and data 
extraction process, the data extraction form will also be updated. 
 
Analysis of the evidence:  
Simple frequency counts of stigma concepts, populations, characteristics or other fields of data 
will be calculated.  
 
Presentation of the results:  
Results of the scoping review will be presented in a table (see Table 2 below for example).  
Table 2: Example tabular presentation of data for a scoping review 
Parameter  Results 
Numbers of 
publications 
1. Total number of sources of evidence 
2. Total numbers between 1955 until January 2021 
3. Number of publications every year 
Types of studies  1. Randomized controlled trials 
2. Non-randomized controlled trials 
3. Quasi-experimental studies 
4. Before-and-after studies 
5. Prospective cohort studies 
6. Retrospective cohort studies 
7. Case-control studies 
8. Cross-sectional studies 
9. Other quantitative studies 
Qualitative studies 
Mixed methods studies 
Population/s identified 1. Population (e.g., parent, patient, healthcare provider, policy-
maker, sibling, other), age, race, sex, gender, ethnicity, DSD 
diagnosis/identity (when applicable) 
Stigma domains  1. Enacted [refers to instances of negative or unfair treatment 
such as discrimination (e.g., not hiring a person with a physical 
difference) and/or other types of unwanted attention/treatment 
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because of the devalued characteristic (e.g., avoiding or 
staring at a person with physical differences, teasing/bullying] 
Felt [Felt stigma refers to the affected individual’s fear of 
enacted stigma or anticipation of social rejection. In other 
words, felt stigma reflects the belief that negative treatment will 
occur if the difference is exposed] 
2. Other (not classified in any of the above) (e.g., 
institutionalized) 
Assessment type 1. Standardized questionnaire 
2. Non-standardized items/questionnaire 
3. Qualitative interviews 
Other methodology 
Assessment measure 4. Measure(s)/assessment battery utilized 
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Appendix A 
 
Ovid MEDLINE  
Ovid MEDLINE(R) and Epub Ahead of Print, In-process & Other Non-INdexed Citations, Daily 
and Versions(R) 
1.  
(17-Hydroxysteroid Dehydrogenase Deficiency OR Anorchia).rs. OR exp Cloaca/ OR exp 
Disorders of Sex Development/ OR exp Hypospadias/ OR exp Intersex Persons/ OR exp 
Kallmann Syndrome/ OR exp Klinefelter Syndrome/ OR exp Ovotesticular Disorders of Sex 
Development/ OR exp Turner Syndrome/ OR exp WAGR Syndrome/ OR Mullerian aplasia.rs. 
OR Mullerian Ducts/ab OR Penis agenesis.rs. OR (17 beta hydroxysteroid dehydrogenase OR 
21-hydroxylase deficiency OR 5 alpha reductase deficiency OR 5-alpha-reductase-2 OR 5alpha-
rd2 deficiency OR 5rd2 deficiency OR adrenal hyperplasia OR adrenogenital syndrome OR 
androgen insensitivity syndrome OR anorchia OR aphallia OR clitoromegaly OR cloaca OR 
cloacal exstrophy OR disorders in androgen synthesis OR empty scrotum OR gonadal regression 
OR hermaphrodite OR hermaphrodites OR hermaphroditism OR hermaphroditismus OR 
hypospadia OR hypospadias OR intersex OR intersexualities OR intersexuality OR kallmann's 
syndrome OR kallmanns syndrome OR luteinizing hormone receptor mutation OR mayer 
rokitansky kuster hauser syndrome OR macroclitoris OR micro-penis OR micropenis OR 
microphallus OR ovotestes OR ovotesticular OR pseudohermaphrodite OR 
pseudohermaphrodites OR pseudohermaphroditism OR sex chromosome mosaicism OR sex 
reversal OR swyer syndrome OR testicular feminization syndrome OR turner's syndrome OR 
turners syndrome OR vanishing testes OR wagr OR wagro).mp. OR ((sex OR sexual) adj3 
(difference OR differences OR differentiation) adj3 (development OR developments)).mp. OR 
((sex OR sexual) adj3 (difference OR differences OR differentiation) adj3 (disorder OR 
disorders)).mp. OR ((sex OR sexual) adj3 (development OR developments) adj3 (disorder OR 
disorders)).mp. OR ((atypical OR atypia OR ambiguous OR ambiguity OR ambiguities) adj3 
(genitalia OR genital OR genitals)).mp. OR (((penis OR penile OR clitoris OR mullerian OR 
gonadal OR uteri OR uterus OR uteruses OR uterovaginal OR vagina OR vaginal OR testis OR 
testes OR testicular) adj3 (dysgenesis OR agenesis OR atresia OR aplasia OR hypoplasia OR 
regression OR absence OR absent OR vanishing)) OR ((uteri OR uterus OR uteruses) adj3 
(didelphys OR bicornus OR absent))).mp.  
 
2.  
exp social stigma/ OR  exp Homophobia/ OR Prejudice/ OR exp Social Discrimination/ OR exp 
Stereotyping/ OR exp Scapegoating/ OR exp Dehumanization/ OR exp Non-Sexual Harassment/ 
OR exp Social Desirability/ OR exp Social Distance/ OR exp Social Isolation/ OR exp Social 
Marginalization/ OR exp Sexual Harassment/ OR exp Incivility/ OR exp Crime Victims/ OR exp 
Violence/ OR exp Workplace Violence/ OR exp Rejection, Psychology/ OR exp sexism/ OR exp 
Human Rights Abuses/ OR exp Attitude to Health/ OR ("gender bias" OR "human rights" OR 
"sex bias" OR "social desirability" OR "social distance" OR "verbal abuse" OR alienation OR 
attitude OR attitudes OR bullied OR bully OR bullying OR dehumanization OR dehumanize OR 
dehumanizing OR discriminate OR discriminated OR discrimination OR disparities OR disparity 
OR harass OR harassed OR harassment OR heteronormative OR heteronormativity OR 
heterosexism OR homonegativity OR homophobia OR homophobic OR incivility OR "social 
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inclusion" OR "social exclusion" OR isolation OR marginalization OR marginalize OR 
marginalized OR marginalise OR marginalised OR marginalisation OR prejudice OR rejection 
OR scapegoat OR scapegoating OR scapegoats OR sexism OR stereotype OR stereotyped OR 
stereotypes OR stereotyping OR stigma OR stigmas OR stigmatize OR stigmatized OR 
stigmatization OR tease OR teased OR teasing OR transphobia OR transphobic OR victim OR 
victimization OR victims OR violence).mp  
 
3. 
(animals.sh. NOT humans.sh.) 
 
(1 AND 2) NOT 3 
Limits: English 
1685 results 12/8/20 
